The Man Who Would Spin Genes Into Gold

See allHide authors and affiliations

Science  13 Aug 1999:
Vol. 285, Issue 5430, pp. 999
DOI: 10.1126/science.285.5430.999

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Human Genome Sciences Inc. of Rockville, Maryland, the company in the forefront of efforts to use modern genomics to develop new drugs (see main text), has three potential therapies based on those genes wending their way through clinical testing. Some attribute the success of company CEO William Haseltine to his practical bent as much as his scientific sense. He likes to explore potential uses for scientific advances, they say--and does so aggressively.